Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
IASO Bio Announces NMPA Approval of IND Application for IASO-782 for Treatment of New Indication -- Systemic Lupus Erythematosus (SLE) 2024-07-25 17:46
AI for Good: Insilico Medicine Hosts IMGAIA Product Launch Event 2024-07-24 21:00
IASO Bio Receives U.S. FDA Approval of Investigational New Drug Application for Equecabtagene Autoleucel for Multiple Sclerosis 2024-07-24 09:52
FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent 2024-07-24 08:10
Telix Successfully Prices A$650 Million Convertible Bonds 2024-07-24 07:51
Origin Agritech Announces Long-Term Revenue Projections Across Key Product Lines Through 2029 2024-07-23 20:00
Telix Announces A$600 Million Convertible Bonds Offering 2024-07-23 16:35
SND Introduces Revolutionary Moderated Drinking Treatment Program 2024-07-23 16:29
QDX Announces Collaboration with Prelude Therapeutics on Novel Oncology Programs 2024-07-23 08:00
DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease 2024-07-23 08:00
Nature Study Reveals: AI and Molecular Dynamics Designed BGM0504 Exhibits Superior Potency 2024-07-22 19:48
Gan & Lee Pharmaceuticals' Bi-weekly (twice a month) GLP-1 Receptor Agonist GZR18 Injection Achieved 17.29% Weight Loss at 30 Weeks in a Phase IIb Clinical Trial 2024-07-22 19:00
Join Hands for a Brighter Future！2024 Tianjin Binhai New Area Innovation and Entrepreneurship Competition Overseas Event (Hong Kong SAR Division) Concluded Successfully 2024-07-22 16:41
Duke-NUS launches LIVE Ventures, a S$20 million incubator to accelerate research commercialisation 2024-07-22 10:00
Agilent Introduces New ProteoAnalyzer at Singapore Cell and Gene Therapy Pan Asia Summit 2024-07-22 09:12
Everest Medicines Announces First Chinese Patient Dosed in Global Phase 2b PALIZADE Trial of Zetomipzomib in Lupus Nephritis 2024-07-22 09:00
Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors 2024-07-22 08:00
Innovent Announces the Second Phase 3 Trial of Mazdutide in Chinese Patients with Type 2 Diabetes Met Study Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA 2024-07-22 08:00
111 Announces Appointment of New Auditor 2024-07-19 20:45
Harbour BioMed Announces Positive Profit Alert for 2024 Interim Results 2024-07-19 07:15
1 21 22 23 24 25 451